Latest News
Thu, 10 May 2012 09:00:00 -0400
Impax Laboratories to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
Tue, 01 May 2012 07:00:00 -0400Impax Laboratories Reports Adjusted First Quarter 2012 EPS of $0.52; GAAP EPS of $0.18
Wed, 18 Apr 2012 08:30:00 -0400View All
Our Divisions
A balanced business model that consists of a successful generic business and a brand strategy to drive higher long-term growth.
Products and Pipeline
An expanding product portfolio with a significant pipeline that renews with our continuing investment in R&D.
